You do not need to fill this in now. A research nurse will go through it with you during your appointment. It is here so you can read it in your own time first.
Informed Consent Form: Menstrual fluid and biopsy
IRAS ID: 356429
Title of Study: Understanding the heterogeneity of reproduction related tissues by multi-level analyses and organoid and cell line derivation (Short title: Bleeds)
Name of Chief Investigator: Roser Vento-Tormo
Name of Principal Investigator at local site: Tulay Karasu
| Number | Statement |
|---|---|
| 1 | I confirm that I have read and understood the information sheet dated 21/10/2026 V1.2 for the above study. I have had the opportunity to consider the information, and my questions have been answered satisfactorily. |
| 2 | I understand that my participation is voluntary and that I am free to withdraw at any time during the study without giving any reason. |
| 3 | I understand that data already collected before withdrawal cannot be withdrawn if it has already been deposited in public databases. |
| 4 | I understand that information I provide may be subject to review by responsible individuals from the Wellcome Sanger Institute and/or regulators for monitoring and audit purposes. |
| 5 | I understand that information I provide will be used in various pseudonymised outputs, including reports, scientific publications and that this includes publication of my sequence data on repositories. |
| 6 | I consent to donating my samples for the purposes stated in the information sheet, including genetic research. |
| 7 | I consent to the generation of organoids and cell lines from my samples. |
| 8 | I agree that my pseudonymised biological samples and data (including DNA and genome sequencing data) may be stored and used by the Wellcome Sanger Institute, or its approved clinical, academic and commercial research partners in the UK and overseas, including for future research. Data shared internationally will be pseudonymised and will be protected at a level similar to that required within the UK |
| 9 | I agree to provide contact details for the consenting team to send me communications about the study, and understand that this will not be shared with the Wellcome Sanger Institute research team. |
| 10 | I agree to take part in this study. |
The following are optional parts of the study. Choosing not to take part in these options will not affect your eligibility to participate in the rest of the study. Please initial yes or no.
| Number | Optional Statement |
|---|---|
| 11 | I agree that if I am already having a biopsy as part of my standard care, an additional sample may be taken for this study. |
| 12 | If needed, I agree to undergo a biopsy for research purposes only. I understand this is not part of my routine clinical care and will not benefit me clinically. |
Signatures
The form ends with space for the name, date and signature of the participant and of the person receiving consent, and for the participant’s email address.
IRAS: 356429 | Menstrual fluid & biopsy ICF | Date: 19/10/2026 | V1.1